Clinicopathological characteristics and outcome of primary sarcomatoid carcinoma of the gallbladder

Bibliographic Details
Title: Clinicopathological characteristics and outcome of primary sarcomatoid carcinoma of the gallbladder
Authors: Rui-Qi Zou, Hai-Jie Hu, Tian-Run Lv, Fei Liu, Wen-Jie Ma, Jun-Ke Wang, Yu-Shi Dai, Si-Qi Yang, Ya-Fei Hu, Fu-Yu Li
Source: Frontiers in Oncology, Vol 12 (2022)
Publisher Information: Frontiers Media S.A., 2022.
Publication Year: 2022
Collection: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Subject Terms: gallbladder, sarcomatoid carcinoma, curative resection, adjuvant chemotherapy, S-1, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
More Details: PurposeOur study aims to examine the clinicopathological features, disease progression, management, and outcomes of gallbladder sarcomatoid carcinoma (GBSC) patients.MethodsBetween January 2000 and December 2020, 50 gallbladder cancer (GBC) patients who received surgical treatment and were pathologically verified as GBSC at our institution were enrolled. The clinical and pathological features and survival of these patients were retrospectively reviewed.ResultsThe median overall survival (OS) of GBSC patients was 14.5 months, and the 1-, 2- and 3-year OS rates were 68.0%, 32.0%, and 10.0%, respectively. The median progression-free survival (PFS) was 10.0 months, and the 1-, 2-, and 3-year PFS rates were 42.0%, 16.0%, and 2.0%, respectively. Patients who received radical resection had obviously better OS (18.0 vs. 7.0 months, P
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2234-943X
Relation: https://www.frontiersin.org/articles/10.3389/fonc.2022.1009673/full; https://doaj.org/toc/2234-943X
DOI: 10.3389/fonc.2022.1009673
Access URL: https://doaj.org/article/dd0b36df2c1e40ee8db1c449d546441a
Accession Number: edsdoj.0b36df2c1e40ee8db1c449d546441a
Database: Directory of Open Access Journals
More Details
ISSN:2234943X
DOI:10.3389/fonc.2022.1009673
Published in:Frontiers in Oncology
Language:English